Relatively, the adverse pathways were “pathogenic escherichia coli infection,” “apoptosis,” “acute myeloid leukemia,” “B cell receptor signaling pathway,” and “chronic myeloid leukemia” (Figure 7F). The gene discussed is PPIB; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.